Effects of pleiotrophin, a heparin-binding growth factor, on human primary and immortalized chondrocytes
Authors:
- G. GrothGGG. Groth
- M.B. GoldringMGM.B. Goldring
- B. TillmannBTB. Tillmann
- R. MentleinR. Mentlein
- 1 February 2007
- journal article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 15 (2) , 155-162
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Midkine and pleiotrophin in neural development and cancerCancer Letters, 2004
- Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritisArthritis & Rheumatism, 2003
- Pleiotrophin/Osteoblast-Stimulating Factor 1: Dissecting Its Diverse Functions in Bone FormationJournal of Bone and Mineral Research, 2002
- Midkine and Pleiotrophin: Two Related Proteins Involved in Development, Survival, Inflammation and TumorigenesisThe Journal of Biochemistry, 2002
- Anti-apoptotic Signaling of Pleiotrophin through Its Receptor, Anaplastic Lymphoma KinaseJournal of Biological Chemistry, 2002
- Identification of Anaplastic Lymphoma Kinase as a Receptor for the Growth Factor PleiotrophinJournal of Biological Chemistry, 2001
- Pleiotrophin signals increased tyrosine phosphorylation of β-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase β/ζProceedings of the National Academy of Sciences, 2000
- Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin–binding growth and differentiation factorsCurrent Opinion in Hematology, 1999
- Signal Transduction Pathways Involved in the Mitogenic Activity of PleiotrophinJournal of Biological Chemistry, 1997
- Pleiotrophin is an abundant protein in dissociative extracts of bovine fetal epiphyseal cartilage and nasal cartilage from newbornsJournal of Orthopaedic Research, 1993